Gastroenteropancreatic (GEP) neuroendocrine tumours (NETs) are fairly rare neoplasms
that present many clinical challenges. They secrete peptides and neuroamines that cause …

Pancreatic endocrine tumors (PETs) have long fascinated clinicians and investigators
despite their relative rarity. Their clinical presentation varies depending on whether the …

Gastrinomas are neuroendocrine neoplasms, usually located in the duodenum or pancreas,
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2
major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the …

Gianfranco Delle Fave a Dik J. Kwekkeboom b Erik Van Cutsem c Guido Rindi d Beata Kos-
Kudla e Ulrich Knigge f Hironobu Sasano g Paola Tomassetti h Ramon Salazar i Philippe …

Background There have been few epidemiological studies on gastroenteropancreatic
neuroendocrine tumors (GEP-NETs) in Japan. Methods We examined the epidemiology of …

Pancreatic endocrine tumors (PETs) have long fascinated clini-cians, because some can
release biologically active hormones that cause distinct syndromes and provide important …

Pancreatic neuroendocrine tumors (pNETs) comprise with gastrointestinal carcinoids, the
main groups of gastrointestinal neuroendocrine tumors (GI-NETs). Although these two …

The mammalian bombesin receptor family comprises three G protein-coupled heptahelical
receptors: the neuromedin B (NMB) receptor (BB1), the gastrin-releasing peptide (GRP) …

Neuroendocrine tumors (NETs) are rare, slow-growing neo-plasms characterized by their
ability to store and secrete different peptides and neuroamines. 1 Some of these substances …